

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 7.01900262 |
| 2 | carnitine shuttle (GO:0006853) | 6.60104338 |
| 3 | fatty acid transmembrane transport (GO:1902001) | 6.30543502 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 6.17233328 |
| 5 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.01695009 |
| 6 | * fatty acid beta-oxidation (GO:0006635) | 5.79805565 |
| 7 | actin-mediated cell contraction (GO:0070252) | 5.58808607 |
| 8 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.48269003 |
| 9 | carnitine transmembrane transport (GO:1902603) | 5.25694026 |
| 10 | lysine metabolic process (GO:0006553) | 5.18402942 |
| 11 | lysine catabolic process (GO:0006554) | 5.18402942 |
| 12 | NADH metabolic process (GO:0006734) | 5.11485061 |
| 13 | * fatty acid oxidation (GO:0019395) | 5.05781777 |
| 14 | * fatty acid catabolic process (GO:0009062) | 5.05259801 |
| 15 | branched-chain amino acid catabolic process (GO:0009083) | 5.01656986 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.01037120 |
| 17 | * lipid oxidation (GO:0034440) | 4.98929335 |
| 18 | amino-acid betaine transport (GO:0015838) | 4.98706685 |
| 19 | carnitine transport (GO:0015879) | 4.98706685 |
| 20 | regulation of cofactor metabolic process (GO:0051193) | 4.98475070 |
| 21 | regulation of coenzyme metabolic process (GO:0051196) | 4.98475070 |
| 22 | regulation of fatty acid oxidation (GO:0046320) | 4.85848912 |
| 23 | acetyl-CoA metabolic process (GO:0006084) | 4.79812728 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 4.77640350 |
| 25 | biotin metabolic process (GO:0006768) | 4.76926732 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 4.64343289 |
| 27 | succinate metabolic process (GO:0006105) | 4.63297899 |
| 28 | respiratory electron transport chain (GO:0022904) | 4.55109150 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 4.54411709 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.53316340 |
| 31 | branched-chain amino acid metabolic process (GO:0009081) | 4.50648853 |
| 32 | valine metabolic process (GO:0006573) | 4.45238690 |
| 33 | electron transport chain (GO:0022900) | 4.42139552 |
| 34 | positive regulation of fatty acid oxidation (GO:0046321) | 4.41065224 |
| 35 | striated muscle contraction (GO:0006941) | 4.37969767 |
| 36 | carnitine metabolic process (GO:0009437) | 4.31712883 |
| 37 | * monocarboxylic acid catabolic process (GO:0072329) | 4.31592420 |
| 38 | skeletal muscle contraction (GO:0003009) | 4.28684197 |
| 39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.26517053 |
| 40 | sarcomere organization (GO:0045214) | 4.26382659 |
| 41 | regulation of sulfur metabolic process (GO:0042762) | 4.22219658 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.19371979 |
| 43 | tricarboxylic acid metabolic process (GO:0072350) | 4.16206094 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.13938754 |
| 45 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.05344240 |
| 46 | actin filament-based movement (GO:0030048) | 4.04639308 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.02901432 |
| 48 | quaternary ammonium group transport (GO:0015697) | 3.95423332 |
| 49 | oxidative phosphorylation (GO:0006119) | 3.94741199 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 3.93290113 |
| 51 | cardiac myofibril assembly (GO:0055003) | 3.90847167 |
| 52 | acyl-CoA biosynthetic process (GO:0071616) | 3.90715427 |
| 53 | thioester biosynthetic process (GO:0035384) | 3.90715427 |
| 54 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.88576594 |
| 55 | ATP synthesis coupled proton transport (GO:0015986) | 3.88576594 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.88186787 |
| 57 | regulation of cell communication by electrical coupling (GO:0010649) | 3.87181324 |
| 58 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.80682669 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79602373 |
| 60 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.78686141 |
| 61 | glyoxylate metabolic process (GO:0046487) | 3.78593267 |
| 62 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.76512462 |
| 63 | heart contraction (GO:0060047) | 3.69526918 |
| 64 | heart process (GO:0003015) | 3.69526918 |
| 65 | response to muscle activity (GO:0014850) | 3.66163820 |
| 66 | ketone body metabolic process (GO:1902224) | 3.65599283 |
| 67 | cardiac muscle hypertrophy (GO:0003300) | 3.65352047 |
| 68 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.64446845 |
| 69 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.59690729 |
| 70 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.57185381 |
| 71 | actomyosin structure organization (GO:0031032) | 3.55865220 |
| 72 | thioester metabolic process (GO:0035383) | 3.55147278 |
| 73 | acyl-CoA metabolic process (GO:0006637) | 3.55147278 |
| 74 | oxaloacetate metabolic process (GO:0006107) | 3.54672819 |
| 75 | gluconeogenesis (GO:0006094) | 3.54101693 |
| 76 | intracellular lipid transport (GO:0032365) | 3.52735270 |
| 77 | glycogen catabolic process (GO:0005980) | 3.51793016 |
| 78 | myofibril assembly (GO:0030239) | 3.51383880 |
| 79 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.49705428 |
| 80 | fatty acid homeostasis (GO:0055089) | 3.48444133 |
| 81 | L-phenylalanine catabolic process (GO:0006559) | 3.48334201 |
| 82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.48334201 |
| 83 | striated muscle hypertrophy (GO:0014897) | 3.47158283 |
| 84 | glucan catabolic process (GO:0009251) | 3.44105545 |
| 85 | regulation of relaxation of muscle (GO:1901077) | 3.43444261 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.42051003 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 3.42051003 |
| 88 | regulation of the force of heart contraction (GO:0002026) | 3.39154530 |
| 89 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.36239630 |
| 90 | ethanol oxidation (GO:0006069) | 3.35348442 |
| 91 | muscle filament sliding (GO:0030049) | 3.34757274 |
| 92 | actin-myosin filament sliding (GO:0033275) | 3.34757274 |
| 93 | creatine metabolic process (GO:0006600) | 3.34617732 |
| 94 | triglyceride catabolic process (GO:0019433) | 3.32149841 |
| 95 | cellular polysaccharide catabolic process (GO:0044247) | 3.31863292 |
| 96 | cardiac muscle contraction (GO:0060048) | 3.28701411 |
| 97 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.27456021 |
| 98 | regulation of actin filament-based movement (GO:1903115) | 3.25721391 |
| 99 | * carboxylic acid catabolic process (GO:0046395) | 3.24590610 |
| 100 | * organic acid catabolic process (GO:0016054) | 3.24590610 |
| 101 | regulation of cholesterol metabolic process (GO:0090181) | 3.23917467 |
| 102 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.23033170 |
| 103 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.21499574 |
| 104 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.21325614 |
| 105 | fructose metabolic process (GO:0006000) | 3.20550472 |
| 106 | hexose biosynthetic process (GO:0019319) | 3.19446646 |
| 107 | lipid particle organization (GO:0034389) | 3.18704057 |
| 108 | regulation of skeletal muscle contraction (GO:0014819) | 3.14794469 |
| 109 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.14639985 |
| 110 | brown fat cell differentiation (GO:0050873) | 3.14540532 |
| 111 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.14531230 |
| 112 | muscle hypertrophy (GO:0014896) | 3.14163378 |
| 113 | regulation of fatty acid metabolic process (GO:0019217) | 3.12814999 |
| 114 | muscle contraction (GO:0006936) | 3.09805743 |
| 115 | positive regulation of lipid storage (GO:0010884) | 3.08634002 |
| 116 | neutral lipid catabolic process (GO:0046461) | 3.07906432 |
| 117 | acylglycerol catabolic process (GO:0046464) | 3.07906432 |
| 118 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.07864701 |
| 119 | muscle tissue morphogenesis (GO:0060415) | 3.07122804 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.05687125 |
| 121 | polysaccharide catabolic process (GO:0000272) | 3.05224900 |
| 122 | response to epinephrine (GO:0071871) | 3.04598600 |
| 123 | glycogen biosynthetic process (GO:0005978) | 3.04018053 |
| 124 | glucan biosynthetic process (GO:0009250) | 3.04018053 |
| 125 | epoxygenase P450 pathway (GO:0019373) | 3.01435016 |
| 126 | quinone biosynthetic process (GO:1901663) | 2.99538550 |
| 127 | ubiquinone biosynthetic process (GO:0006744) | 2.99538550 |
| 128 | regulation of striated muscle contraction (GO:0006942) | 2.98585536 |
| 129 | heart trabecula formation (GO:0060347) | 2.98031897 |
| 130 | low-density lipoprotein particle clearance (GO:0034383) | 2.95952247 |
| 131 | cardiac muscle cell development (GO:0055013) | 2.95017294 |
| 132 | long-chain fatty acid transport (GO:0015909) | 2.92578659 |
| 133 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.92408258 |
| 134 | monosaccharide biosynthetic process (GO:0046364) | 2.92117314 |
| 135 | phospholipid homeostasis (GO:0055091) | 2.91781618 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.89996933 |
| 137 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.89664672 |
| 138 | response to inactivity (GO:0014854) | 2.85616609 |
| 139 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83309736 |
| 140 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.83253264 |
| 141 | angiotensin maturation (GO:0002003) | 2.82965815 |
| 142 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.82805106 |
| 143 | adult heart development (GO:0007512) | 2.79960174 |
| 144 | muscle system process (GO:0003012) | 2.78051590 |
| 145 | cellular response to epinephrine stimulus (GO:0071872) | 2.76556551 |
| 146 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.74495875 |
| 147 | peroxisome fission (GO:0016559) | 2.73997028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.46203251 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.36015444 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.08141905 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.58703071 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.29230911 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.68223689 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.51726325 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.42314420 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.16162011 |
| 10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.98359996 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60410792 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.60323731 |
| 13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.53379727 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.52124815 |
| 15 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.14815695 |
| 16 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.14815695 |
| 17 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.2153252 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84404021 |
| 19 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.79694019 |
| 20 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78241824 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74566360 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.73679306 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.73343129 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59309345 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51848339 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51780743 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48777821 |
| 28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.48759085 |
| 29 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46755197 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45396167 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43795489 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39620706 |
| 33 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.33893158 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29444943 |
| 35 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.26420404 |
| 36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19461813 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19441094 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14523320 |
| 39 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12478306 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10369611 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07811286 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06902136 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04591159 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04492520 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04492520 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03955512 |
| 47 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03752313 |
| 48 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.03193629 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99079767 |
| 50 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98139977 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97972657 |
| 52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96132407 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95913096 |
| 54 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.95776902 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95504741 |
| 56 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94900161 |
| 57 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94494958 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94236031 |
| 59 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.94019246 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93991218 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90099462 |
| 62 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89190152 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88482676 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.87589063 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86989101 |
| 66 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85797952 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85738601 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85390544 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84829214 |
| 70 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83467554 |
| 71 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82101764 |
| 72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81826006 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80154429 |
| 74 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79880436 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79784897 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78731294 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78548776 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.78290150 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78241686 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77576237 |
| 81 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.76817761 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76524214 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.75395689 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74666788 |
| 85 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.73714129 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73422728 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72566896 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72183705 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71344510 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.71249708 |
| 91 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71035563 |
| 92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.70918996 |
| 93 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69748102 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.69155230 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69136633 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69001409 |
| 97 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68939308 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68538208 |
| 99 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.68175290 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66150881 |
| 101 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66112450 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65964109 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65521606 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.64859621 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64841051 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63015747 |
| 107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62957750 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.61557452 |
| 109 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.61063383 |
| 110 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.60779745 |
| 111 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.60455542 |
| 112 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60432966 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59481757 |
| 114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58245923 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58107593 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.57910312 |
| 117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.57333315 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.56501224 |
| 119 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56477878 |
| 120 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.54930954 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.53881686 |
| 122 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52402036 |
| 123 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52159411 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.52127524 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.52127524 |
| 126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.51101307 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.50918673 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.50918673 |
| 129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50156777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.16746493 |
| 2 | MP0003646_muscle_fatigue | 4.36170138 |
| 3 | MP0004130_abnormal_muscle_cell | 3.67014298 |
| 4 | MP0005670_abnormal_white_adipose | 3.58036099 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.57454955 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.45726763 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.42271541 |
| 8 | MP0000751_myopathy | 3.13183466 |
| 9 | * MP0005330_cardiomyopathy | 2.95811534 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.93118774 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.91966451 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.91278460 |
| 13 | MP0005360_urolithiasis | 2.89918121 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.78633937 |
| 15 | MP0005365_abnormal_bile_salt | 2.75597590 |
| 16 | MP0000749_muscle_degeneration | 2.59793132 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.57549032 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.25110222 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.24667711 |
| 20 | * MP0004087_abnormal_muscle_fiber | 2.13775276 |
| 21 | MP0005332_abnormal_amino_acid | 2.12870257 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 2.08805221 |
| 23 | MP0003195_calcinosis | 2.08302863 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.03972760 |
| 25 | MP0005620_abnormal_muscle_contractility | 2.00252110 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.93888584 |
| 27 | MP0005375_adipose_tissue_phenotype | 1.90354175 |
| 28 | * MP0002971_abnormal_brown_adipose | 1.89371955 |
| 29 | * MP0005385_cardiovascular_system_phenoty | 1.89348470 |
| 30 | * MP0001544_abnormal_cardiovascular_syste | 1.89348470 |
| 31 | MP0006138_congestive_heart_failure | 1.82761807 |
| 32 | MP0004484_altered_response_of | 1.77184417 |
| 33 | * MP0002118_abnormal_lipid_homeostasis | 1.75827145 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.72973454 |
| 35 | MP0000750_abnormal_muscle_regeneration | 1.71804372 |
| 36 | * MP0010630_abnormal_cardiac_muscle | 1.70393009 |
| 37 | MP0004043_abnormal_pH_regulation | 1.67582549 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.66003439 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.65938380 |
| 40 | * MP0003137_abnormal_impulse_conducting | 1.63770073 |
| 41 | MP0002269_muscular_atrophy | 1.62671863 |
| 42 | MP0005535_abnormal_body_temperature | 1.57056993 |
| 43 | MP0000747_muscle_weakness | 1.49623673 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.47408402 |
| 45 | MP0003252_abnormal_bile_duct | 1.45164976 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41152588 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.40634598 |
| 48 | MP0009840_abnormal_foam_cell | 1.39502469 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.39209441 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.36955756 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.33945982 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.33668233 |
| 53 | MP0005369_muscle_phenotype | 1.32046332 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.31524681 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.31313576 |
| 56 | MP0005451_abnormal_body_composition | 1.27602667 |
| 57 | MP0003828_pulmonary_edema | 1.26727914 |
| 58 | * MP0004085_abnormal_heartbeat | 1.26597257 |
| 59 | * MP0000609_abnormal_liver_physiology | 1.26546437 |
| 60 | * MP0000759_abnormal_skeletal_muscle | 1.24565305 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.22630324 |
| 62 | * MP0002078_abnormal_glucose_homeostasis | 1.21464326 |
| 63 | MP0001661_extended_life_span | 1.18499865 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.18023080 |
| 65 | MP0005334_abnormal_fat_pad | 1.15704117 |
| 66 | MP0003186_abnormal_redox_activity | 1.15454622 |
| 67 | MP0001666_abnormal_nutrient_absorption | 1.11606140 |
| 68 | MP0003868_abnormal_feces_composition | 1.08838317 |
| 69 | MP0000230_abnormal_systemic_arterial | 1.08078081 |
| 70 | MP0005266_abnormal_metabolism | 1.04556765 |
| 71 | MP0003011_delayed_dark_adaptation | 1.03131029 |
| 72 | MP0005165_increased_susceptibility_to | 1.01757795 |
| 73 | MP0000343_altered_response_to | 1.00778691 |
| 74 | MP0005083_abnormal_biliary_tract | 0.99011796 |
| 75 | MP0004147_increased_porphyrin_level | 0.94337786 |
| 76 | MP0002127_abnormal_cardiovascular_syste | 0.94037154 |
| 77 | MP0009115_abnormal_fat_cell | 0.92572574 |
| 78 | MP0004233_abnormal_muscle_weight | 0.90279173 |
| 79 | MP0005166_decreased_susceptibility_to | 0.86790883 |
| 80 | MP0002970_abnormal_white_adipose | 0.86709302 |
| 81 | MP0003690_abnormal_glial_cell | 0.85524457 |
| 82 | MP0003075_altered_response_to | 0.82282321 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.80474039 |
| 84 | MP0001764_abnormal_homeostasis | 0.79115864 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.77680603 |
| 86 | MP0005448_abnormal_energy_balance | 0.73478965 |
| 87 | MP0001756_abnormal_urination | 0.71989545 |
| 88 | MP0000733_abnormal_muscle_development | 0.71160030 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.69208704 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.68745293 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.67512334 |
| 92 | MP0005452_abnormal_adipose_tissue | 0.63950525 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.61410968 |
| 94 | MP0001853_heart_inflammation | 0.60837625 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.60622550 |
| 96 | MP0003329_amyloid_beta_deposits | 0.59832652 |
| 97 | MP0003941_abnormal_skin_development | 0.59674360 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.58037288 |
| 99 | MP0004272_abnormal_basement_membrane | 0.58003536 |
| 100 | MP0000604_amyloidosis | 0.57458884 |
| 101 | * MP0000266_abnormal_heart_morphology | 0.57398872 |
| 102 | MP0005275_abnormal_skin_tensile | 0.57388492 |
| 103 | MP0002108_abnormal_muscle_morphology | 0.56823141 |
| 104 | MP0000249_abnormal_blood_vessel | 0.56697690 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.56595230 |
| 106 | MP0004510_myositis | 0.56363061 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.55919742 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.55618571 |
| 109 | * MP0009642_abnormal_blood_homeostasis | 0.55377663 |
| 110 | MP0009763_increased_sensitivity_to | 0.54427019 |
| 111 | MP0003953_abnormal_hormone_level | 0.54399679 |
| 112 | MP0005636_abnormal_mineral_homeostasis | 0.53758359 |
| 113 | MP0003279_aneurysm | 0.53683839 |
| 114 | MP0009697_abnormal_copulation | 0.53052863 |
| 115 | MP0003959_abnormal_lean_body | 0.51747441 |
| 116 | MP0002132_abnormal_respiratory_system | 0.50492500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.40818738 |
| 2 | Nemaline bodies (HP:0003798) | 6.36255109 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.28005479 |
| 4 | Hypoglycemic coma (HP:0001325) | 5.37270230 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.07308676 |
| 6 | * Myoglobinuria (HP:0002913) | 4.96934564 |
| 7 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.96486801 |
| 8 | Sudden death (HP:0001699) | 4.60290841 |
| 9 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.57987297 |
| 10 | Dicarboxylic aciduria (HP:0003215) | 4.57987297 |
| 11 | Hepatic necrosis (HP:0002605) | 4.53849507 |
| 12 | Exercise-induced myalgia (HP:0003738) | 4.49559594 |
| 13 | Hyperglycinuria (HP:0003108) | 4.47554146 |
| 14 | Ketoacidosis (HP:0001993) | 4.37249140 |
| 15 | Ventricular tachycardia (HP:0004756) | 4.06917367 |
| 16 | Ketosis (HP:0001946) | 4.00231342 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.92348408 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92348408 |
| 19 | * Rhabdomyolysis (HP:0003201) | 3.86016668 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.85820056 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 3.79400390 |
| 22 | Cerebral edema (HP:0002181) | 3.79173367 |
| 23 | Palpitations (HP:0001962) | 3.78412021 |
| 24 | Acute encephalopathy (HP:0006846) | 3.78096048 |
| 25 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.75192383 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 3.73516760 |
| 27 | Neck muscle weakness (HP:0000467) | 3.72279708 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.70691397 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.68365978 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 3.65871764 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.65705238 |
| 32 | * Hyperammonemia (HP:0001987) | 3.64469553 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 3.61662143 |
| 34 | Hepatocellular necrosis (HP:0001404) | 3.54139683 |
| 35 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.50847191 |
| 36 | Lipoatrophy (HP:0100578) | 3.40654537 |
| 37 | Atrial fibrillation (HP:0005110) | 3.36912180 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 3.33385258 |
| 39 | Muscle fiber splitting (HP:0003555) | 3.25905133 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 3.22953531 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.22811751 |
| 42 | Rimmed vacuoles (HP:0003805) | 3.15125167 |
| 43 | Progressive macrocephaly (HP:0004481) | 3.11977563 |
| 44 | Myopathic facies (HP:0002058) | 3.11832176 |
| 45 | Increased CSF lactate (HP:0002490) | 3.09107971 |
| 46 | Mitochondrial inheritance (HP:0001427) | 3.07090393 |
| 47 | Primary atrial arrhythmia (HP:0001692) | 3.04908208 |
| 48 | * Dilated cardiomyopathy (HP:0001644) | 3.03738967 |
| 49 | Hyperglycinemia (HP:0002154) | 3.02541394 |
| 50 | Abnormality of glycolysis (HP:0004366) | 3.02336856 |
| 51 | Increased serum pyruvate (HP:0003542) | 3.02336856 |
| 52 | Increased intramyocellular lipid droplets (HP:0012240) | 3.01660829 |
| 53 | * Lactic acidosis (HP:0003128) | 3.01565085 |
| 54 | Renal cortical cysts (HP:0000803) | 2.99460406 |
| 55 | Lethargy (HP:0001254) | 2.99309374 |
| 56 | Syncope (HP:0001279) | 2.98522906 |
| 57 | Distal arthrogryposis (HP:0005684) | 2.96931393 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.93843902 |
| 59 | Supraventricular tachycardia (HP:0004755) | 2.93342907 |
| 60 | Nausea (HP:0002018) | 2.93143737 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.91635272 |
| 62 | Supraventricular arrhythmia (HP:0005115) | 2.87279055 |
| 63 | Increased variability in muscle fiber diameter (HP:0003557) | 2.87173242 |
| 64 | Metabolic acidosis (HP:0001942) | 2.85195785 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.84561898 |
| 66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.77558544 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.77558544 |
| 68 | Hyperalaninemia (HP:0003348) | 2.77558544 |
| 69 | Lipid accumulation in hepatocytes (HP:0006561) | 2.75152621 |
| 70 | Xanthomatosis (HP:0000991) | 2.74483615 |
| 71 | Atrioventricular block (HP:0001678) | 2.72765562 |
| 72 | Round ear (HP:0100830) | 2.69902693 |
| 73 | Bundle branch block (HP:0011710) | 2.69878658 |
| 74 | Conjunctival hamartoma (HP:0100780) | 2.68579698 |
| 75 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65347230 |
| 76 | Hyperlipoproteinemia (HP:0010980) | 2.65311948 |
| 77 | Muscle stiffness (HP:0003552) | 2.62515836 |
| 78 | Difficulty running (HP:0009046) | 2.60525564 |
| 79 | Heart block (HP:0012722) | 2.59348653 |
| 80 | Pheochromocytoma (HP:0002666) | 2.56438195 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.55858854 |
| 82 | Vomiting (HP:0002013) | 2.52451122 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.52274939 |
| 84 | Methylmalonic aciduria (HP:0012120) | 2.50805133 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.50460092 |
| 86 | Ulnar deviation of the wrist (HP:0003049) | 2.47431675 |
| 87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.45317569 |
| 88 | Increased connective tissue (HP:0009025) | 2.44669228 |
| 89 | Exercise intolerance (HP:0003546) | 2.43608967 |
| 90 | Ventricular arrhythmia (HP:0004308) | 2.42716523 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 2.39812967 |
| 92 | Complement deficiency (HP:0004431) | 2.39795566 |
| 93 | * Respiratory failure (HP:0002878) | 2.38061442 |
| 94 | Prolonged QT interval (HP:0001657) | 2.37971614 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 2.37411911 |
| 96 | Frequent falls (HP:0002359) | 2.33606587 |
| 97 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.33460389 |
| 98 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.33460389 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 2.31612676 |
| 100 | Hypolipoproteinemia (HP:0010981) | 2.31347250 |
| 101 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.30838131 |
| 102 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30360889 |
| 103 | Glycosuria (HP:0003076) | 2.30168902 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 2.30168902 |
| 105 | Ventricular fibrillation (HP:0001663) | 2.28342239 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 2.27523549 |
| 107 | Areflexia of lower limbs (HP:0002522) | 2.26990115 |
| 108 | Methylmalonic acidemia (HP:0002912) | 2.24986234 |
| 109 | EMG: myopathic abnormalities (HP:0003458) | 2.19653420 |
| 110 | Ragged-red muscle fibers (HP:0003200) | 2.19587027 |
| 111 | Hyperglycemia (HP:0003074) | 2.18911018 |
| 112 | Oligomenorrhea (HP:0000876) | 2.17948471 |
| 113 | Subaortic stenosis (HP:0001682) | 2.17579685 |
| 114 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17579685 |
| 115 | Hypoglycemic seizures (HP:0002173) | 2.15538164 |
| 116 | Increased serum lactate (HP:0002151) | 2.13553504 |
| 117 | Bulbar palsy (HP:0001283) | 2.12485110 |
| 118 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10225584 |
| 119 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08909333 |
| 120 | Gowers sign (HP:0003391) | 2.05135369 |
| 121 | * Generalized muscle weakness (HP:0003324) | 2.05038154 |
| 122 | Neoplasm of the adrenal gland (HP:0100631) | 2.04566059 |
| 123 | Esophageal neoplasm (HP:0100751) | 2.03172153 |
| 124 | Neoplasm of head and neck (HP:0012288) | 2.03172153 |
| 125 | Skin nodule (HP:0200036) | 2.00999766 |
| 126 | Abnormality of the foot musculature (HP:0001436) | 1.97227513 |
| 127 | Distal lower limb amyotrophy (HP:0008944) | 1.95891558 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91520766 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91520766 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91520766 |
| 131 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89353166 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.87826191 |
| 133 | Abnormality of complement system (HP:0005339) | 1.81544173 |
| 134 | Foot dorsiflexor weakness (HP:0009027) | 1.77236561 |
| 135 | Axonal loss (HP:0003447) | 1.75359280 |
| 136 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.73789878 |
| 137 | Limb-girdle muscle atrophy (HP:0003797) | 1.73405338 |
| 138 | Scapular winging (HP:0003691) | 1.73370615 |
| 139 | Myotonia (HP:0002486) | 1.73008091 |
| 140 | Weak cry (HP:0001612) | 1.71498674 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.69632382 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.69632382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.26321646 |
| 2 | PDK4 | 4.77494718 |
| 3 | PDK3 | 4.77494718 |
| 4 | TTN | 3.73141897 |
| 5 | LMTK2 | 3.48364108 |
| 6 | OBSCN | 3.48288951 |
| 7 | PDK2 | 3.18287060 |
| 8 | PHKG1 | 3.00013397 |
| 9 | PHKG2 | 3.00013397 |
| 10 | TRIB3 | 2.89216940 |
| 11 | PKN2 | 2.51957847 |
| 12 | MYLK | 2.49947653 |
| 13 | TIE1 | 2.28573109 |
| 14 | PINK1 | 2.18324988 |
| 15 | INSRR | 2.13120606 |
| 16 | WNK4 | 1.77772702 |
| 17 | PIK3CA | 1.77498384 |
| 18 | MUSK | 1.67091462 |
| 19 | LIMK1 | 1.65169279 |
| 20 | STK24 | 1.62238658 |
| 21 | NEK1 | 1.60627276 |
| 22 | SIK1 | 1.60037772 |
| 23 | STK39 | 1.49339517 |
| 24 | PRKAA2 | 1.48060831 |
| 25 | CAMK1D | 1.42888971 |
| 26 | DMPK | 1.42104131 |
| 27 | FLT3 | 1.41603942 |
| 28 | MAP3K12 | 1.39573232 |
| 29 | GRK7 | 1.38185468 |
| 30 | STK16 | 1.33589650 |
| 31 | TESK1 | 1.26237185 |
| 32 | SCYL2 | 1.21495555 |
| 33 | STK38L | 1.21461581 |
| 34 | NEK9 | 1.09180449 |
| 35 | EIF2AK3 | 1.08812229 |
| 36 | EPHB1 | 1.05500009 |
| 37 | CAMK2D | 1.02797827 |
| 38 | ZAK | 1.00784527 |
| 39 | MAP3K2 | 1.00255954 |
| 40 | FGFR4 | 0.98463722 |
| 41 | KDR | 0.95661110 |
| 42 | PRKAA1 | 0.95504473 |
| 43 | PRKD1 | 0.93649216 |
| 44 | PBK | 0.89018555 |
| 45 | ACVR1B | 0.88641345 |
| 46 | IRAK3 | 0.86753444 |
| 47 | ERBB3 | 0.85847895 |
| 48 | KSR2 | 0.85650183 |
| 49 | PAK3 | 0.84041632 |
| 50 | PIK3CG | 0.83522504 |
| 51 | MAPK12 | 0.80652620 |
| 52 | MAP2K6 | 0.78745419 |
| 53 | CAMK1G | 0.78323372 |
| 54 | PDPK1 | 0.77341740 |
| 55 | EPHA3 | 0.76175298 |
| 56 | TBK1 | 0.75612296 |
| 57 | MST1R | 0.74668576 |
| 58 | MAP3K7 | 0.70805507 |
| 59 | MAP2K3 | 0.70803883 |
| 60 | ILK | 0.68846131 |
| 61 | MOS | 0.68835138 |
| 62 | PKN1 | 0.68189845 |
| 63 | MAP3K3 | 0.67485439 |
| 64 | ERN1 | 0.66499557 |
| 65 | FGFR3 | 0.66000038 |
| 66 | EIF2AK1 | 0.65778219 |
| 67 | PRKACG | 0.61584031 |
| 68 | LATS1 | 0.60813834 |
| 69 | MAP3K6 | 0.60424792 |
| 70 | ROCK1 | 0.58656002 |
| 71 | WNK1 | 0.57918835 |
| 72 | IRAK1 | 0.57455622 |
| 73 | CAMK2G | 0.57406327 |
| 74 | PDK1 | 0.56653238 |
| 75 | ZAP70 | 0.53402699 |
| 76 | MAP3K1 | 0.52248781 |
| 77 | TGFBR2 | 0.51391035 |
| 78 | DAPK3 | 0.51198353 |
| 79 | LATS2 | 0.49431772 |
| 80 | RIPK1 | 0.48936992 |
| 81 | DDR2 | 0.48723766 |
| 82 | WNK3 | 0.47317068 |
| 83 | PRKACA | 0.46419506 |
| 84 | MAPK11 | 0.46173639 |
| 85 | IRAK2 | 0.45389054 |
| 86 | NME2 | 0.44667387 |
| 87 | MET | 0.44478666 |
| 88 | MAPK7 | 0.44342362 |
| 89 | JAK1 | 0.42686189 |
| 90 | PIM2 | 0.42634852 |
| 91 | FGFR2 | 0.42173683 |
| 92 | TRPM7 | 0.41927607 |
| 93 | CAMK2A | 0.39898216 |
| 94 | PTK6 | 0.39676547 |
| 95 | CAMK4 | 0.38360156 |
| 96 | OXSR1 | 0.38353160 |
| 97 | PRKCE | 0.38351508 |
| 98 | PRKG1 | 0.37761561 |
| 99 | FRK | 0.37583650 |
| 100 | CAMK2B | 0.36726810 |
| 101 | ABL2 | 0.36675880 |
| 102 | MAP2K1 | 0.36612619 |
| 103 | DYRK1B | 0.35667959 |
| 104 | MAPKAPK3 | 0.35473067 |
| 105 | STK4 | 0.35058118 |
| 106 | PRKCH | 0.34807631 |
| 107 | PRKACB | 0.34527799 |
| 108 | PRKCQ | 0.34273200 |
| 109 | CDK6 | 0.33904351 |
| 110 | CDC42BPA | 0.33787958 |
| 111 | PDGFRA | 0.33749858 |
| 112 | JAK2 | 0.32274695 |
| 113 | RAF1 | 0.31702491 |
| 114 | CAMK1 | 0.31156128 |
| 115 | MAP3K5 | 0.30662466 |
| 116 | TYK2 | 0.30615114 |
| 117 | MAP2K4 | 0.30467389 |
| 118 | PAK4 | 0.29344887 |
| 119 | PTK2 | 0.28967669 |
| 120 | CCNB1 | 0.28134441 |
| 121 | SGK223 | 0.26626665 |
| 122 | SGK494 | 0.26626665 |
| 123 | KIT | 0.26479709 |
| 124 | MAPK15 | 0.24061514 |
| 125 | ERBB4 | 0.23076544 |
| 126 | ROCK2 | 0.22030345 |
| 127 | GSK3A | 0.21684133 |
| 128 | IGF1R | 0.20484400 |
| 129 | SGK3 | 0.20393779 |
| 130 | AKT2 | 0.20089757 |
| 131 | FER | 0.19653631 |
| 132 | RET | 0.19054238 |
| 133 | MAPK4 | 0.18499957 |
| 134 | PRKG2 | 0.14959201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.98579689 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.33884036 |
| 3 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.81877445 |
| 4 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.55302489 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.54217301 |
| 6 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 3.25084032 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74101197 |
| 8 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.44935318 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44699857 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.44065886 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.43714304 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31431829 |
| 13 | * Fatty acid elongation_Homo sapiens_hsa00062 | 2.29409045 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.22837029 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11070188 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09644511 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05147419 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97264070 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.90434589 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76571701 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74762980 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.70553230 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.67599776 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.66918761 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53463722 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53240327 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52699311 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42645204 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38799998 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29915668 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27263382 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26365775 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.18388665 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15787411 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13567727 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13370494 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12762528 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01129492 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00767258 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99958118 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99940945 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96010208 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95877709 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93657616 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92661386 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92420651 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90905033 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88700512 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85193618 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82694460 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81330215 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79821891 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77197657 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76696008 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.73796112 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.73575947 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73467563 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73067816 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.72280478 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70781787 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69474200 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.65998356 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.65962533 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64383010 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.62608615 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61544868 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58319817 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57711404 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57690791 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57272015 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.56340521 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54980565 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53331963 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50853410 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50353928 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46391665 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43710044 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42315056 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42270332 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42191346 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39694809 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39172035 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38850513 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37574840 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37337280 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35861459 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.33470721 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32336923 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30636233 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.28511769 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28196446 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27833185 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.26830573 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26570745 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24943223 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21898386 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.19355329 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.16391857 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16387846 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15048237 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.13339201 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12819719 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08465273 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07140298 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.06715536 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.03271874 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.02754630 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.02417268 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0552145 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0303557 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | -0.0229297 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0056880 |

